Theranos
Theranos' Emergency Authorization Bid for Zika Assay Raises Questions About Strategic Direction
Facing CMS sanctions, lab industry insiders ponder the firm's options in seeking to launch a Zika virus assay with emergency use authorization on its upcoming miniLab platform.
Theranos Offers First Glimpse of Technologies, Assay Data to Critical Lab Community
At the American Association for Clinical Chemistry meeting, Theranos CEO Elizabeth Holmes said her company is working on third-party review and publications of the firm's technologies and tests.